LADENBURG THALM/SH SH Has Lowered Expectations for electroCore (NASDAQ:ECOR) Stock Price

electroCore (NASDAQ:ECOR) had its price target decreased by investment analysts at LADENBURG THALM/SH SH from $28.00 to $26.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. LADENBURG THALM/SH SH’s price target points to a potential upside of 203.74% from the stock’s current price.

Separately, HC Wainwright restated a “buy” rating and set a $25.00 price objective on shares of electroCore in a research note on Thursday.

electroCore Stock Down 10.4 %

Shares of NASDAQ ECOR opened at $8.56 on Thursday. electroCore has a fifty-two week low of $5.32 and a fifty-two week high of $19.49. The firm’s 50-day simple moving average is $15.84 and its 200 day simple moving average is $12.26. The stock has a market cap of $56.98 million, a P/E ratio of -4.68 and a beta of 0.24.

Institutional Investors Weigh In On electroCore

Several hedge funds and other institutional investors have recently bought and sold shares of ECOR. HighTower Advisors LLC bought a new stake in electroCore in the third quarter worth about $255,000. Geode Capital Management LLC raised its position in electroCore by 10.3% in the third quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after acquiring an additional 5,951 shares in the last quarter. JPMorgan Chase & Co. raised its position in electroCore by 31,250.0% in the fourth quarter. JPMorgan Chase & Co. now owns 3,762 shares of the company’s stock worth $61,000 after acquiring an additional 3,750 shares in the last quarter. DnB Asset Management AS purchased a new position in electroCore in the 4th quarter worth about $180,000. Finally, Renaissance Technologies LLC increased its stake in electroCore by 80.6% in the 4th quarter. Renaissance Technologies LLC now owns 131,786 shares of the company’s stock worth $2,136,000 after purchasing an additional 58,800 shares in the last quarter. 26.74% of the stock is currently owned by institutional investors.

electroCore Company Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.